Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

China Resources Pharmaceutical Group Limited

3320.HK

Valuace

Růst

Zdraví

Cena

$ 6.15

0.00 (0.00%)

Výsledovka

Rozvaha

Peněžní toky

V miliardách (HKD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Total Revenues	571.9	292.4	274.2	270.4	254.1	236.8	200.4	204.5	189.7	172.5	156.7	146.6	135.7	117.0
Cost of Revenues	479.5	244.1	230.9	227.0	215.0	201.4	168.1	170.4	154.8	144.3	132.6	123.4	114.3	96.8
Gross Profit	92.5	48.3	43.3	43.4	39.1	35.4	32.3	34.0	34.9	28.3	24.1	23.2	21.5	20.1

Revenue	4-2025	2-2025	4-2024	2-2024	4-2023	2-2023	2-2019	1-2019	4-2018	2-2018
Total Revenues	150.8	144.5	137.3	139.4	130.5	138.9	51.1	51.1	51.1	47.4
Cost of Revenues	125.6	120.9	116.3	116.7	110.6	116.6	42.6	42.6	42.6	38.7
Gross Profit	25.2	23.6	21.0	22.7	19.9	22.3	8.5	8.5	8.5	8.7

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
R&D Expenses	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling General & Admin Expenses	0.0	0.0	0.0	28.2	25.5	23.8	21.6	24.4	23.1	18.1	14.8	14.0	13.0	12.1
Depreciation & Amortization	7.1	4.4	2.7	3.2	3.2	2.8	2.4	2.4	1.6	1.6	1.3	1.3	1.4	1.2
Total Operating Expenses	65.8	34.8	30.7	29.4	25.0	23.2	21.0	24.4	23.1	18.1	14.9	14.0	13.0	12.1
Operating Income	26.6	13.4	12.9	12.1	13.3	11.7	11.1	9.7	12.2	10.9	9.8	8.9	8.9	8.5

Operating Income	TTM	4-2025	2-2025	4-2024	2-2024	4-2023	2-2023	2-2019	1-2019	4-2018	2-2018
R&D Expenses	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	14.1	14.4	6.1	6.1	6.1	5.8
Depreciation & Amortization	2.4	1.6	1.3	1.8	1.4	1.7	0.6	0.6	0.6	0.4
Total Operating Expenses	19.0	15.5	16.2	15.1	15.5	15.3	6.1	6.1	6.1	0.3
Operating Income	6.2	8.0	4.8	7.6	4.3	7.0	2.1	2.1	2.1	2.1

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Interest Income	1.2	0.5	0.7	0.6	0.8	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest Expense	4.7	2.2	2.3	2.4	2.9	2.7	3.2	3.7	2.9	2.2	1.8	2.1	2.1	1.8
Other Expense	-2.2	-0.6	-1.3	-2.3	-3.5	-3.3	-4.0	-3.1	-2.9	-2.3	-1.8	-0.9	-1.9	-1.6
IBT	24.5	12.8	11.6	9.9	9.9	8.4	7.1	6.6	9.2	8.6	8.0	8.1	6.9	6.9
Income Tax Expense	5.1	2.3	2.7	2.1	2.0	1.8	1.8	1.5	1.6	1.7	2.1	2.0	1.4	1.5
Net Income	8.0	4.4	3.6	3.9	7.8	6.6	5.3	5.1	4.0	3.5	2.8	2.9	2.6	2.6

Net Income	TTM	4-2025	2-2025	4-2024	2-2024	4-2023	2-2023	2-2019	1-2019	4-2018	2-2018
Interest Income	0.2	0.3	0.3	0.4	0.3	0.3	0.0	0.0	0.0	0.0
Interest Expense	1.1	1.1	1.2	1.3	0.8	1.6	0.9	0.9	0.9	0.7
Other Expense	-0.3	-1.0	-0.7	-0.1	-0.5	-0.2	-0.5	-0.5	-0.5	0.2
IBT	5.9	7.0	4.1	7.4	3.8	6.9	1.7	1.7	1.7	2.3
Income Tax Expense	0.9	1.5	1.1	1.6	0.9	1.4	0.4	0.4	0.4	0.4
Net Income	2.2	2.3	0.8	2.8	1.2	3.0	1.3	1.3	1.3	1.9

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
EPS	$0.00	$0.00	$0.00	$0.61	$1.25	$1.06	$0.85	$0.81	$0.64	$0.55	$0.57	$0.46	$0.43	$0.43
EPS Diluted	$0.00	$0.00	$0.00	$0.61	$1.25	$1.06	$0.85	$0.81	$0.64	$0.55	$0.57	$0.46	$0.43	$0.43
Shares Outstanding	6.3	6.3	6.3	6.3	6.3	6.3	6.3	6.3	6.3	6.3	4.9	6.2	6.2	6.2
Diluted Shares Outstanding	6.3	6.3	6.3	6.3	6.3	6.3	6.3	6.3	6.3	6.3	4.9	6.2	6.2	6.2

Per Share Data	TTM	4-2025	2-2025	4-2024	2-2024	4-2023	2-2023	2-2019	1-2019	4-2018	2-2018
EPS	$0.00	$0.00	$0.00	$0.00	$0.19	$0.48	$0.20	$0.20	$0.20	$0.30
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.19	$0.48	$0.20	$0.20	$0.20	$0.30
Shares Outstanding	6.3	6.3	6.5	6.3	6.3	6.3	6.3	6.3	6.3	6.3
Diluted Shares Outstanding	6.3	6.3	6.3	6.3	6.3	6.3	6.3	6.3	6.3	6.3

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash And Equivalents	30.1	17.5	24.7	17.0	17.5	11.2	12.5	16.6	14.2	14.0	12.4	13.4	15.2
Short Term Investments	42.7	0.0	34.6	35.0	40.3	34.6	26.4	28.0	6.6	3.6	6.3	5.6	1.8
Total Cash & ST Investments	72.8	17.5	59.3	52.1	57.8	45.8	38.9	44.7	20.7	17.6	18.7	19.0	16.9
Accounts Receivable	92.0	108.2	82.6	0.0	0.0	0.0	0.0	62.1	71.0	57.3	54.9	49.5	39.6
Inventory	39.8	39.4	31.9	29.7	29.7	24.6	22.3	21.5	21.4	18.9	15.3	15.7	12.2
Other Current Assets	7.8	32.7	4.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1
Total Current Assets	212.3	197.8	178.6	170.5	176.6	147.1	132.9	128.4	113.2	93.8	88.9	84.3	68.8

Current Assets	2-2025	4-2024	2-2024	4-2023	2-2023	4-2022	2-2022	4-2021	2-2021	4-2020
Cash And Equivalents	19.4	17.5	30.1	24.7	32.4	17.0	18.4	17.5	17.0	11.2
Short Term Investments	15.1	0.0	11.6	34.6	6.7	35.0	41.8	40.3	35.2	34.6
Total Cash & ST Investments	34.5	17.5	41.7	59.3	39.1	52.1	60.2	57.8	52.2	45.8
Accounts Receivable	121.6	108.2	92.0	75.6	112.6	0.0	0.0	0.0	0.0	0.0
Inventory	46.0	39.4	39.8	31.9	34.9	29.7	29.1	29.7	27.1	24.6
Other Current Assets	20.4	32.7	38.9	87.4	6.6	0.0	97.7	89.2	91.3	76.7
Total Current Assets	222.5	197.8	212.3	178.6	200.9	170.5	187.0	176.6	170.6	147.1

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Property, Plant & Equipment	26.6	26.3	25.4	24.7	25.5	22.9	22.1	14.9	15.0	12.8	13.1	13.5	12.9
Goodwill	23.1	22.4	21.5	22.8	24.9	21.1	19.3	19.8	20.5	17.4	16.4	15.3	14.9
Intangible Assets	0.0	8.5	8.0	8.5	9.1	7.0	6.2	7.6	7.4	6.1	6.8	6.3	6.0
Long-Term Investments	9.2	6.5	-27.7	-24.7	-32.4	-28.3	-21.2	-25.5	-4.0	-1.6	-5.7	-4.7	-0.7
Other Long-Term Assets	13.0	12.7	41.1	37.9	43.5	38.6	29.8	30.5	8.0	5.0	7.3	6.6	2.6
Total Long-Term Assets	73.9	76.5	68.2	70.8	72.0	62.3	57.1	47.9	47.6	40.2	38.3	37.5	36.0
Total Assets	286.2	274.3	271.5	241.3	248.6	209.4	190.0	176.2	160.8	134.0	127.1	121.8	104.8

Long-Term Assets	2-2025	4-2024	2-2024	4-2023	2-2023	4-2022	2-2022	4-2021	2-2021	4-2020
Net Property, Plant & Equipment	35.0	26.3	26.6	25.4	26.1	24.7	23.8	25.5	22.9	22.9
Goodwill	26.6	22.4	23.1	21.5	23.4	22.8	23.8	24.9	21.4	21.1
Intangible Assets	12.1	8.5	8.5	8.0	32.5	8.5	8.6	9.1	7.0	7.0
Long-Term Investments	8.0	6.5	9.2	8.6	9.7	-24.7	-34.1	-32.4	-28.8	-28.3
Other Long-Term Assets	10.1	12.7	4.5	3.0	-21.8	37.9	45.9	43.5	39.8	38.6
Total Long-Term Assets	91.8	76.5	73.9	68.2	71.8	70.8	69.3	72.0	63.4	62.3
Total Assets	314.3	274.3	286.2	246.8	272.7	241.3	256.3	248.6	234.0	209.4

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Accounts Payable	47.6	42.6	54.5	54.7	52.4	45.7	42.7	39.5	42.2	39.8	33.4	30.8	24.7
Short-Term Debt	74.0	48.2	46.2	41.2	48.4	41.0	30.4	40.8	33.4	19.3	24.3	20.4	20.2
Other Current Liabilities	27.9	49.8	32.8	40.4	0.0	0.0	0.0	0.0	16.1	11.8	14.5	14.3	14.0
Current Liabilities	154.7	140.7	134.2	136.3	141.3	122.6	106.7	103.4	91.7	71.0	72.2	65.5	58.9

Current Liabilities	2-2025	4-2024	2-2024	4-2023	2-2023	4-2022	2-2022	4-2021	2-2021	4-2020
Accounts Payable	60.1	42.6	47.6	54.5	20.4	54.7	54.0	52.4	50.7	45.7
Short-Term Debt	62.1	48.2	74.4	46.2	65.6	41.2	58.0	48.4	62.5	41.0
Other Current Liabilities	50.4	49.8	31.8	32.1	73.1	40.4	34.8	0.0	0.0	0.0
Current Liabilities	158.1	140.7	154.7	134.2	159.7	136.3	146.8	141.3	140.5	122.6

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Long-Term Debt	22.4	25.1	15.9	11.0	8.1	3.2	10.9	10.1	3.4	6.4	12.9	16.9	11.1
Capital Leases	0.9	1.4	1.3	1.4	1.5	1.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	1.8	2.0	1.7	1.8	2.0	1.7	1.5	0.9	1.0	0.9	0.9	0.8	0.7
Total Liabilities	181.9	169.9	169.2	151.1	153.6	129.3	120.4	115.7	97.6	79.7	87.3	84.6	72.2

Long-Term Liabilities	2-2025	4-2024	2-2024	4-2023	2-2023	4-2022	2-2022	4-2021	2-2021	4-2020
Long-Term Debt	28.9	25.1	23.3	15.9	13.4	11.0	12.5	8.1	5.5	3.2
Capital Leases	1.4	1.4	1.3	1.3	1.0	1.4	1.5	1.5	1.7	1.9
Def. Tax Liability	0.0	2.0	1.8	1.7	2.0	1.8	1.9	2.0	1.7	1.7
Total Liabilities	191.6	169.9	181.9	153.8	177.3	151.1	163.3	153.6	149.7	129.3

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Common Stock	26.5	26.2	27.1	27.2	27.2	27.2	27.2	27.2	27.2	27.2	12.5	12.5	4.6
Retained Earnings	0.0	33.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Comprehensive Income	0.0	-7.9	-8.6	0.0	0.0	0.0	0.0	-6.1	-5.9	-4.6	-4.2	-3.9	-3.9
Total Common Equity	52.0	51.3	50.6	49.6	51.0	46.5	40.7	39.4	41.9	37.6	22.5	20.5	18.0

Total Common Equity	2-2025	4-2024	2-2024	4-2023	2-2023	4-2022	2-2022	4-2021	2-2021	4-2020
Common Stock	27.0	26.2	26.5	24.6	27.2	27.2	27.2	27.2	27.2	27.2
Retained Earnings	36.5	33.0	33.1	32.7	33.0	0.0	0.0	0.0	0.0	0.0
Comprehensive Income	-8.7	-8.5	-8.2	-9.2	-10.6	0.0	0.0	0.0	0.0	0.0
Total Common Equity	54.8	51.3	52.0	46.0	50.4	49.6	50.5	51.0	48.7	46.5

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Total Debt		97.3	73.4	62.2	52.2	56.5	44.2	41.3	50.9	36.9	25.7	37.2	37.3	31.2
Book Value		104.4	104.4	102.3	90.2	95.0	80.0	69.6	60.5	63.1	54.3	39.8	37.2	32.6

Other		2-2025	4-2024	2-2024	4-2023	2-2023	4-2022	2-2022	4-2021	2-2021	4-2020
Total Debt		68.0	53.0	52.4	47.0	45.0	40.6	42.5	44.0	35.6	33.6
Book Value		54.8	51.3	52.0	46.0	50.4	49.6	50.5	51.0	48.7	46.5

Cash Flow From Operating Activities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	7.9	3.6	9.9	9.9	8.4	7.1	6.6	9.2	8.6	8.0	8.1	6.9	6.9
Depreciation & Amortization	5.8	0.0	3.5	3.2	2.8	2.4	2.4	1.6	1.6	1.3	1.3	1.4	1.2
Stock-Based Compensation	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Change Working Capital	-0.1	3.1	1.6	-0.9	0.3	-3.8	-2.0	-3.0	-5.1	-4.2	-2.2	-3.6	-3.7
Change In Accounts Receivable	-6.9	-7.6	-7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Change In Accounts Payable	11.0	15.7	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Change In Inventories	-3.1	-5.4	-2.9	-2.6	-3.4	-0.8	-0.5	0.0	-0.7	-4.5	-0.2	-3.8	-1.1
Other Non-cash Items	25.0	10.7	0.4	0.4	2.5	2.4	1.1	0.4	-0.2	-1.0	-1.2	-0.4	-0.3
Cash from Operations	19.0	0.0	15.5	12.6	12.8	8.2	8.1	8.2	4.9	4.1	6.0	4.2	4.1

Cash Flow From Operating Activities	2-2025	4-2024	2-2024	4-2023	2-2023	2-2019	1-2019	4-2018	2-2018	1-2018
Net Income	2.3	0.8	2.8	1.2	3.0	0.8	0.8	0.8	1.0	1.0
Depreciation & Amortization	2.1	0.0	1.8	1.8	1.7	0.6	0.6	0.6	0.4	0.4
Stock-Based Compensation	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
Change Working Capital	-10.9	13.4	-10.3	13.7	-13.3	-0.5	-0.5	-0.5	-0.8	-0.8
Change In Accounts Receivable	-7.7	8.6	-16.2	12.5	-19.4	0.0	0.0	0.0	0.0	0.0
Change In Accounts Payable	0.0	4.7	10.9	0.0	11.0	0.0	0.0	0.0	0.0	0.0
Change In Inventories	-3.2	0.2	-5.6	1.5	-4.5	-0.1	-0.1	-0.1	0.0	0.0
Other Non-cash Items	7.5	5.2	3.8	4.6	19.2	1.1	1.1	1.1	1.4	1.4
Cash from Operations	0.0	0.0	0.0	21.4	-5.5	2.0	2.0	2.0	2.1	2.1

Cash Flow From Investing Activities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Capital Expenditure	-3.4	-3.5	-3.5	-3.5	-3.1	-2.2	-2.0	-2.0	-2.0	-1.8	-2.4	-3.2	-3.0
Acquisitions	0.4	0.5	0.6	-0.7	-2.6	-0.5	-0.4	-2.3	-3.6	-3.0	-0.5	-1.0	-3.6
Investments	-17.9	-37.6	-24.1	-33.6	-28.3	-35.8	-35.6	-21.1	-7.2	-15.5	-16.6	-15.1	-4.3
Sales of Investment	20.6	35.5	22.4	32.5	25.1	35.6	39.0	17.0	3.4	18.3	15.9	10.9	2.9
Other Investing Activities	-0.3	0.0	2.5	4.4	-0.3	0.6	0.0	-1.4	0.9	0.1	-0.3	0.3	2.2
Cash from Investing	3.1	0.0	-2.1	-0.9	-9.2	-2.3	1.0	-9.8	-8.5	-2.0	-3.9	-8.0	-5.8

Cash Flow From Investing Activities	2-2025	2-2024	4-2023	2-2023	2-2019	1-2019	4-2018	2-2018	1-2018
Capital Expenditure	-1.4	-1.3	-1.5	-1.4	-0.5	-0.5	-0.5	0.0	0.0
Acquisitions	-5.5	2.0	-1.0	1.4	0.0	0.0	0.0	0.0	0.0
Investments	0.0	-0.1	0.0	-9.0	-8.9	-8.9	-8.9	-5.3	-5.3
Sales of Investment	0.0	15.8	0.0	10.8	9.8	9.8	9.8	4.2	4.2
Other Investing Activities	0.0	0.0	0.0	0.1	-0.3	-0.3	-0.3	1.0	1.0
Cash from Investing	0.0	0.0	-2.6	1.9	0.1	0.1	0.1	-1.1	-1.1

Cash Flow From Financing Activities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Debt Repaid	-34.6	0.0	-0.2	-107.1	-87.2	-59.8	-79.9	-70.3	-54.4	-45.2	-45.3	-38.3	-27.8
Debt Issued	346.7	11.3	10.2	102.7	99.5	62.7	70.2	84.3	65.5	33.7	45.3	44.3	59.0
Issuance of Common Stock	0.0	0.0	0.0	0.0	86.9	55.3	0.0	0.0	0.0	15.1	0.0	0.0	5.3
Repurchase of Common Stock	0.0	-3.9	-0.5	-0.5	-0.1	-0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	-1.2	0.0	-1.0	-0.9	-0.8	-0.7	-0.8	-0.7	-0.6	0.0	0.0	0.0	0.0
Other Financing Activities	3.6	0.0	-2.7	96.8	4.1	-1.0	67.7	75.6	58.0	29.5	43.8	41.3	26.5
Cash from Financing	-18.0	0.0	-4.5	-11.7	3.0	-6.4	-13.0	4.7	3.1	-0.6	-1.6	3.1	4.0

Cash Flow From Financing Activities	2-2025	4-2024	2-2024	4-2023	2-2023	2-2019	1-2019	4-2018	2-2018	1-2018
Debt Repaid	0.0	0.0	0.0	0.0	0.0	-20.0	-20.0	-20.0	-17.6	-17.6
Debt Issued	91.0	73.4	97.3	62.2	90.7	81.9	70.9	70.9	62.9	54.4
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Repurchase of Common Stock	0.0	-3.8	-0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	-1.0	0.0	-0.2	-0.2	-0.2	-0.2	-0.2
Other Financing Activities	0.0	0.0	0.0	-15.1	12.7	20.2	20.2	20.2	17.7	17.7
Cash from Financing	0.0	0.0	0.0	-16.1	12.7	-17.0	-17.0	-17.0	-18.9	-18.9

Cash position		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Change in Cash		8.4	-8.1	9.4	-0.5	6.3	-1.3	-4.1	2.5	0.2	0.8	-0.5	-1.4	2.5
Closing Cash Balance		30.1	26.7	24.7	17.1	17.5	11.2	12.5	16.6	14.2	14.0	13.2	13.7	15.2

Cash position		2-2025	4-2024	2-2024	4-2023	2-2023	2-2019	1-2019	4-2018	2-2018	1-2018
Net Change in Cash		4.3	-3.3	-2.3	3.5	8.3	-1.0	-1.0	-1.0	0.6	0.6
Closing Cash Balance		19.4	26.7	30.1	27.4	32.4	3.1	3.1	3.1	4.2	4.2

Free Cash Flow		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Free Cash Flow		15.6	14.5	12.4	9.1	9.7	6.0	6.1	6.3	2.9	2.3	3.6	1.0	1.1
Real Free Cash Flow		15.4	14.5	12.3	9.0	9.7	6.0	6.1	6.3	2.9	2.3	3.6	1.0	1.1

Free Cash Flow		2-2025	4-2024	2-2024	4-2023	2-2023	2-2019	1-2019	4-2018	2-2018	1-2018
Free Cash Flow		0.3	17.6	-2.2	19.9	-6.9	1.5	1.5	1.5	2.1	2.1
Real Free Cash Flow		0.3	17.6	-2.3	19.8	-7.0	1.5	1.5	1.5	2.1	2.1